Literature DB >> 15862113

Relative contribution of PDX-1, MafA and E47/beta2 to the regulation of the human insulin promoter.

Hilary M Docherty1, Colin W Hay, Laura A Ferguson, John Barrow, Elaine Durward, Kevin Docherty.   

Abstract

The insulin promoter binds a number of tissue-specific and ubiquitous transcription factors. Of these, the homoeodomain protein PDX-1 (pancreatic duodenal homeobox factor-1), the basic leucine zipper protein MafA and the basic helix-loop-helix heterodimer E47/BETA2 (beta-cell E box transactivator 2; referred to here as beta2) bind to important regulatory sites. Previous studies have shown that PDX-1 can interact synergistically with E47 and beta2 to activate the rat insulin 1 promoter. The aim of the present study was to determine the relative contribution of PDX-1, MafA and E47/beta2 in regulating the human insulin promoter, and whether these factors could interact synergistically in the context of the human promoter. Mutagenesis of the PDX-1, MafA and E47/beta2 binding sites reduced promoter activity by 60, 74 and 94% respectively, in INS-1 beta-cells. In the islet glucagonoma cell line alphaTC1.6, overexpression of PDX-1 and MafA separately increased promoter activity approx. 2.5-3-fold, and in combination approx. 6-fold, indicating that their overall effect was additive. Overexpression of E47 and beta2 had no effect. In HeLa cells, PDX-1 stimulated the basal promoter by approx. 40-fold, whereas MafA, E47 and beta2 each increased activity by less than 2-fold. There was no indication of any synergistic effects on the human insulin promoter. On the other hand, the rat insulin 1 promoter and a mutated version of the human insulin promoter, in which the relevant regulatory elements were separated by the same distances as in the rat insulin 1 promoter, did exhibit synergy. PDX-1 was shown further to activate the endogenous insulin 1 gene in alphaTC1.6 cells, whereas MafA activated the insulin 2 gene. In combination, PDX-1 and MafA activated both insulin genes. Chromatin immunoprecipitation assays confirmed that PDX-1 increased the association of acetylated histones H3 and H4 with the insulin 1 gene and MafA increased the association of acetylated histone H3 with the insulin 2 gene.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15862113      PMCID: PMC1180732          DOI: 10.1042/BJ20041891

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  48 in total

1.  The islet beta cell-enriched MafA activator is a key regulator of insulin gene transcription.

Authors:  Li Zhao; Min Guo; Taka-Aki Matsuoka; Derek K Hagman; Susan D Parazzoli; Vincent Poitout; Roland Stein
Journal:  J Biol Chem       Date:  2005-01-20       Impact factor: 5.157

2.  Structure-function analysis of the rat prolactin promoter: phasing requirements of proximal cell-specific elements.

Authors:  C Harvey; S M Jackson; S K Siddiqui; A Gutierrez-Hartmann
Journal:  Mol Endocrinol       Date:  1991-06

3.  Positive and negative regulation of the human insulin gene by multiple trans-acting factors.

Authors:  D S Boam; A R Clark; K Docherty
Journal:  J Biol Chem       Date:  1990-05-15       Impact factor: 5.157

4.  Proglucagon processing similar to normal islets in pancreatic alpha-like cell line derived from transgenic mouse tumor.

Authors:  A C Powers; S Efrat; S Mojsov; D Spector; J F Habener; D Hanahan
Journal:  Diabetes       Date:  1990-04       Impact factor: 9.461

5.  Insulin expression in pancreatic islet cells relies on cooperative interactions between the helix loop helix factor E47 and the homeobox factor STF-1.

Authors:  B Peers; J Leonard; S Sharma; G Teitelman; M R Montminy
Journal:  Mol Endocrinol       Date:  1994-12

6.  The insulin and islet amyloid polypeptide genes contain similar cell-specific promoter elements that bind identical beta-cell nuclear complexes.

Authors:  M S German; L G Moss; J Wang; W J Rutter
Journal:  Mol Cell Biol       Date:  1992-04       Impact factor: 4.272

7.  Characterization of somatostatin transactivating factor-1, a novel homeobox factor that stimulates somatostatin expression in pancreatic islet cells.

Authors:  J Leonard; B Peers; T Johnson; K Ferreri; S Lee; M R Montminy
Journal:  Mol Endocrinol       Date:  1993-10

8.  Establishment of 2-mercaptoethanol-dependent differentiated insulin-secreting cell lines.

Authors:  M Asfari; D Janjic; P Meda; G Li; P A Halban; C B Wollheim
Journal:  Endocrinology       Date:  1992-01       Impact factor: 4.736

9.  c-Jun represses the human insulin promoter activity that depends on multiple cAMP response elements.

Authors:  N Inagaki; T Maekawa; T Sudo; S Ishii; Y Seino; H Imura
Journal:  Proc Natl Acad Sci U S A       Date:  1992-02-01       Impact factor: 11.205

10.  IPF1, a homeodomain-containing transactivator of the insulin gene.

Authors:  H Ohlsson; K Karlsson; T Edlund
Journal:  EMBO J       Date:  1993-11       Impact factor: 11.598

View more
  38 in total

1.  ATF2 interacts with beta-cell-enriched transcription factors, MafA, Pdx1, and beta2, and activates insulin gene transcription.

Authors:  Song-iee Han; Kunio Yasuda; Kohsuke Kataoka
Journal:  J Biol Chem       Date:  2011-01-28       Impact factor: 5.157

2.  The nuclear orphan receptor Nur77 is a lipotoxicity sensor regulating glucose-induced insulin secretion in pancreatic β-cells.

Authors:  Olivier Briand; Audrey Helleboid-Chapman; Maheul Ploton; Nathalie Hennuyer; Rodolphe Carpentier; François Pattou; Brigitte Vandewalle; Ericka Moerman; Valery Gmyr; Julie Kerr-Conte; Jérôme Eeckhoute; Bart Staels; Philippe Lefebvre
Journal:  Mol Endocrinol       Date:  2012-02-02

3.  Cx36 is a target of Beta2/NeuroD1, which associates with prenatal differentiation of insulin-producing β cells.

Authors:  Rachel Nlend Nlend; Aouatef Aït-Lounis; Florent Allagnat; Valentina Cigliola; Anne Charollais; Walter Reith; Jacques-Antoine Haefliger; Paolo Meda
Journal:  J Membr Biol       Date:  2012-06-23       Impact factor: 1.843

4.  miR-25 and miR-92a regulate insulin I biosynthesis in rats.

Authors:  Dwi Setyowati Karolina; Sugunavathi Sepramaniam; Hui Zhing Tan; Arunmozhiarasi Armugam; Kandiah Jeyaseelan
Journal:  RNA Biol       Date:  2013-08       Impact factor: 4.652

5.  Role of phospholipase D1 in glucose-induced insulin secretion in pancreatic Beta cells.

Authors:  Wei-na Ma; Shin-Young Park; Joong-Soo Han
Journal:  Exp Mol Med       Date:  2010-06-30       Impact factor: 8.718

6.  Effect of FIGF overexpression on liver cells transforming to insulin-producing cells.

Authors:  Yaqin He; Xiaoliang Xie; Xiaoyan Li; Shikuo Rong; Yukui Li; Zhenhui Lu
Journal:  J Biosci       Date:  2019-12       Impact factor: 1.826

7.  Chronic Exposure to Proline Causes Aminoacidotoxicity and Impaired Beta-Cell Function: Studies In Vitro.

Authors:  Zhenping Liu; Per B Jeppesen; Søren Gregersen; Lotte Bach Larsen; Kjeld Hermansen
Journal:  Rev Diabet Stud       Date:  2016-05-10

8.  A model of insulin resistance in mice, born to diabetic pregnancy, is associated with alterations of transcription-related genes in pancreas and epididymal adipose tissue.

Authors:  Akadiri Yessoufou; Kabirou Moutairou; Naim Akhtar Khan
Journal:  J Obes       Date:  2010-09-26

9.  miRNA-30a-5p-mediated silencing of Beta2/NeuroD expression is an important initial event of glucotoxicity-induced beta cell dysfunction in rodent models.

Authors:  J-W Kim; Y-H You; S Jung; H Suh-Kim; I-K Lee; J-H Cho; K-H Yoon
Journal:  Diabetologia       Date:  2013-01-22       Impact factor: 10.122

10.  Involvement of Per-Arnt-Sim Kinase and extracellular-regulated kinases-1/2 in palmitate inhibition of insulin gene expression in pancreatic beta-cells.

Authors:  Ghislaine Fontés; Meriem Semache; Derek K Hagman; Caroline Tremblay; Ramila Shah; Christopher J Rhodes; Jared Rutter; Vincent Poitout
Journal:  Diabetes       Date:  2009-06-05       Impact factor: 9.461

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.